Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency
AssigneeCorcept Therapeutics, Inc.
InventorsAndreas G. MORAITIS, Pejman COHAN, Joseph K. BELANOFF
Life of this patent
Estimating the term…
Loading patent…
AssigneeCorcept Therapeutics, Inc.
InventorsAndreas G. MORAITIS, Pejman COHAN, Joseph K. BELANOFF
Estimating the term…
This invention provides for a method of h eating secondary adrenal insufficiency by co-administrating therapeutically effective amounts of a glucocorticoid and a glucocorticoid receptor antagonist to the patient in need thereof. In some embodiments, the method includes the proviso that the patient not be otherwise in need of treatment with a glucocorticoid and a glucocorticoid receptor antagonist. The treatment method can increase the patient's morning or basal cortisol level to at least about 12 μg/dL or a standard control level, and in turn, expedite significantly the recovery of the HPA axis. The method provided herein can improve health outcomes and life-threatening complications associated with secondary adrenal insufficiency.
A method of treating secondary adrenal insufficiency, the method comprising co-administering a therapeutically effective amount of a glucocorticoid (GC) and a non-steroidal glucocorticoid receptor antagonist (GRA) to a patient in need thereof effective to increase the patient's morning plasma levels of cortisol to at least about 12 μg/dL, whereby said secondary adrenal insufficiency is treated.
Dependencies are inferred from the claim text.